Literature DB >> 7021718

Excess alpha chains are lost from beta-thalassemic reticulocytes by proteolysis.

U Testa, N Hinard, Y Beuzard, A Tsapis, F Galacteros, P Thomopoulos, J Rosa.   

Abstract

During incubation of reticulocytes from patients with beta-thalassemia, after labeling of the hemoglobin with radioactive amino acids, the excess alpha chains are gradually lost from the cells. The aim of this study was to investigate the mechanism of this phenomenon. A system was developed in which reticulocytes from beta-thalassemia patients are labeled with [3H]leucine, washed several times in nonradioactive medium, and then incubated in the same medium containing puromycin added in order to stop further protein synthesis. The results have clearly shown that excess alpha chains are gradually degraded by proteolysis. N-ethylmaleimide or epsilon-aminocaproic acid inhibited the proteolysis of free alpha chains. The addition of either ATP or hemin did not change the rate of alpha chain degradation. The time required to degrade 50% of the pool of free alpha chains was directly dependent on the initial value of this pool. This finding suggests the absence of a significant individual variation in the ability to proteolyse free alpha chains.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021718

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  2 in total

1.  Hemoglobin Evanston (alpha 14 Trp----Arg). An unstable alpha-chain variant expressed as alpha-thalassemia.

Authors:  G R Honig; M Shamsuddin; L N Vida; M Mompoint; E Valcourt; L J Bowie; E C Jones; P A Powers; R A Spritz; M Guis
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

2.  Hemoglobin Mississippi (beta 44ser----cys). Studies of the thalassemic phenotype in a mixed heterozygote with beta +-thalassemia.

Authors:  M H Steinberg; J G Adams; W T Morrison; D J Pullen; R Abney; A Ibrahim; R F Rieder
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.